Patent Foramen Ovale in Patients with Sickle Cell Disease and Stroke: Case Presentations and Review of the Literature
Although individuals with sickle cell disease (SCD) are at increased risk for stroke, the underlying pathophysiology is incompletely understood. Intracardiac shunting via a patent foramen ovale (PFO) is associated with cryptogenic stroke in individuals without SCD. Recent evidence suggests that PFOs...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2013/516705 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832565421459374080 |
---|---|
author | Sheila Razdan John J. Strouse Rakhi Naik Sophie Lanzkron Victor Urrutia Jon R. Resar Linda M. S. Resar |
author_facet | Sheila Razdan John J. Strouse Rakhi Naik Sophie Lanzkron Victor Urrutia Jon R. Resar Linda M. S. Resar |
author_sort | Sheila Razdan |
collection | DOAJ |
description | Although individuals with sickle cell disease (SCD) are at increased risk for stroke, the underlying pathophysiology is incompletely understood. Intracardiac shunting via a patent foramen ovale (PFO) is associated with cryptogenic stroke in individuals without SCD. Recent evidence suggests that PFOs are associated with stroke in children with SCD, although the role of PFOs in adults with stroke and SCD is unknown. Here, we report 2 young adults with SCD, stroke, and PFOs. The first patient had hemoglobin SC and presented with a transient ischemic attack and a subsequent ischemic stroke. There was no evidence of cerebral vascular disease on imaging studies and the PFO was closed. The second patient had hemoglobin SS and two acute ischemic strokes. She had cerebral vascular disease with moyamoya in addition to a peripheral deep venous thrombosis (DVT). Chronic transfusion therapy was recommended, and the DVT was managed with warfarin. The PFO was not closed, and the patients' neurologic symptoms were stabilized. We review the literature on PFOs and stroke in SCD. Our cases and the literature review illustrate the dire need for further research to evaluate PFO as a potential risk factor for stroke in adults with SCD. |
format | Article |
id | doaj-art-0f959932842e4feea39166217b0a7c4f |
institution | Kabale University |
issn | 2090-6560 2090-6579 |
language | English |
publishDate | 2013-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Hematology |
spelling | doaj-art-0f959932842e4feea39166217b0a7c4f2025-02-03T01:07:33ZengWileyCase Reports in Hematology2090-65602090-65792013-01-01201310.1155/2013/516705516705Patent Foramen Ovale in Patients with Sickle Cell Disease and Stroke: Case Presentations and Review of the LiteratureSheila Razdan0John J. Strouse1Rakhi Naik2Sophie Lanzkron3Victor Urrutia4Jon R. Resar5Linda M. S. Resar6Hematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USAHematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USAHematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USAHematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USANeurology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USACardiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USAHematology Division, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USAAlthough individuals with sickle cell disease (SCD) are at increased risk for stroke, the underlying pathophysiology is incompletely understood. Intracardiac shunting via a patent foramen ovale (PFO) is associated with cryptogenic stroke in individuals without SCD. Recent evidence suggests that PFOs are associated with stroke in children with SCD, although the role of PFOs in adults with stroke and SCD is unknown. Here, we report 2 young adults with SCD, stroke, and PFOs. The first patient had hemoglobin SC and presented with a transient ischemic attack and a subsequent ischemic stroke. There was no evidence of cerebral vascular disease on imaging studies and the PFO was closed. The second patient had hemoglobin SS and two acute ischemic strokes. She had cerebral vascular disease with moyamoya in addition to a peripheral deep venous thrombosis (DVT). Chronic transfusion therapy was recommended, and the DVT was managed with warfarin. The PFO was not closed, and the patients' neurologic symptoms were stabilized. We review the literature on PFOs and stroke in SCD. Our cases and the literature review illustrate the dire need for further research to evaluate PFO as a potential risk factor for stroke in adults with SCD.http://dx.doi.org/10.1155/2013/516705 |
spellingShingle | Sheila Razdan John J. Strouse Rakhi Naik Sophie Lanzkron Victor Urrutia Jon R. Resar Linda M. S. Resar Patent Foramen Ovale in Patients with Sickle Cell Disease and Stroke: Case Presentations and Review of the Literature Case Reports in Hematology |
title | Patent Foramen Ovale in Patients with Sickle Cell Disease and Stroke: Case Presentations and Review of the Literature |
title_full | Patent Foramen Ovale in Patients with Sickle Cell Disease and Stroke: Case Presentations and Review of the Literature |
title_fullStr | Patent Foramen Ovale in Patients with Sickle Cell Disease and Stroke: Case Presentations and Review of the Literature |
title_full_unstemmed | Patent Foramen Ovale in Patients with Sickle Cell Disease and Stroke: Case Presentations and Review of the Literature |
title_short | Patent Foramen Ovale in Patients with Sickle Cell Disease and Stroke: Case Presentations and Review of the Literature |
title_sort | patent foramen ovale in patients with sickle cell disease and stroke case presentations and review of the literature |
url | http://dx.doi.org/10.1155/2013/516705 |
work_keys_str_mv | AT sheilarazdan patentforamenovaleinpatientswithsicklecelldiseaseandstrokecasepresentationsandreviewoftheliterature AT johnjstrouse patentforamenovaleinpatientswithsicklecelldiseaseandstrokecasepresentationsandreviewoftheliterature AT rakhinaik patentforamenovaleinpatientswithsicklecelldiseaseandstrokecasepresentationsandreviewoftheliterature AT sophielanzkron patentforamenovaleinpatientswithsicklecelldiseaseandstrokecasepresentationsandreviewoftheliterature AT victorurrutia patentforamenovaleinpatientswithsicklecelldiseaseandstrokecasepresentationsandreviewoftheliterature AT jonrresar patentforamenovaleinpatientswithsicklecelldiseaseandstrokecasepresentationsandreviewoftheliterature AT lindamsresar patentforamenovaleinpatientswithsicklecelldiseaseandstrokecasepresentationsandreviewoftheliterature |